A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy. Academic Article uri icon

Overview

authors

  • Grivas, Petros
  • Tagawa, Scott T.
  • Jain, Rohit
  • Bupathi, Manojkumar
  • Balar, Arjun
  • Rezazadeh Kalebasty, Arash
  • George, Saby
  • Palmbos, Phillip
  • Nordquist, Luke
  • Petrylak, Daniel P
  • Davis, Nancy
  • Sternberg, Cora
  • Agarwal, Neeraj
  • Park, Chandler
  • Tonelli, Julia
  • Zhou, Huafeng
  • Bangs, Rick
  • Loriot, Yohann

publication date

  • September 1, 2025

Identity

PubMed Central ID

  • PMC12490376

Scopus Document Identifier

  • 105014900445

Digital Object Identifier (DOI)

  • 10.1080/14796694.2025.2548757

PubMed ID

  • 40888442

Additional Document Info

volume

  • 21

issue

  • 23